Rua Bioscience burns through $6.2m

Rua Bioscience burns through $6.2m
Rua: R&D spending up. (Image: Supplied)
Brent Melville
Listed medicinal cannabis firm Rua Bioscience almost doubled its cash burn rate for the year to June, recording a loss before tax of $6.17 million, from a loss of $3.59m last year.That was after research and development spending jumped to $1.9m, from $1.29m in 2020, reflecting the costs of developing the firm’s product lines, and investment into cultivation and manufacturing. The East Coast-based firm’s income came in the form of a government research and development grant of $357,366 and a covid wage subsidy of $91,636. It emp...

More Markets

NZ sharemarket flat amid Tourism Holdings trading halt
Markets Market close

NZ sharemarket flat amid Tourism Holdings trading halt

The S&P/NZX 50 Index closed at 11,874.04, up 6.46 points or 0.05%.

THL halts trading on 'materially lower' earnings expectations
Markets

THL halts trading on 'materially lower' earnings expectations

In February THL's net profit guidance for FY2024 was $75m.

BNZ's 1H profit and margins ease
Markets

BNZ's 1H profit and margins ease

Net profit was down 5.3% on the previous year's first half. 

NZ sharemarket falls due to global inflation fears
Markets Market close

NZ sharemarket falls due to global inflation fears

The S&P/NZX 50 Index closed at 11,867.58, down 89.92 points or 0.75%.

Graham Skellern 01 May 2024